GNH USA

Europe — EMA

Minirin (Desmopressin Acetate)

GNH USA supplies Minirin (Desmopressin Acetate), a vasopressin analog for diabetes insipidus, nocturnal enuresis and bleeding disorders. Request a quote.

Request sourcing

1
Pack/s

What is Desmopressin Acetate?

Desmopressin acetate, the active ingredient in Minirin, is a vasopressin analog presented as an oral formulation for oral use. It is employed to treat central diabetes insipidus, nocturnal enuresis, primary nocturnal polyuria, hemophilia A, and von Willebrand disease.

GNH USA supplies Minirin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Desmopressin Acetate used for?

Desmopressin acetate acts on the antidiuretic hormone pathway to manage disorders of water balance and certain bleeding disorders.

- Central diabetes insipidus: reduces excessive urine output by increasing renal water reabsorption. - Nocturnal enuresis: decreases nighttime bedwetting episodes by concentrating urine. - Primary nocturnal polyuria: lowers nocturnal urine volume to improve sleep quality. - Hemophilia A: raises plasma factor VIII levels to improve clotting. - Von Willebrand disease: enhances release of von Willebrand factor to support hemostasis.

What are the side effects of Desmopressin Acetate?

Desmopressin acetate may cause a range of adverse reactions. Monitoring and patient education are important.

Common Side Effects: - Headache: mild to moderate intensity. - Nausea: occasional gastrointestinal upset. - Hyponatremia: mild reduction in serum sodium. - Abdominal cramps: transient discomfort. - Facial flushing: brief reddening of skin. - Dizziness: light‑headed sensation.

Serious or Rare Side Effects: - Water intoxication: severe hyponatremia with cerebral edema. - Seizures: secondary to profound hyponatremia. - Allergic reactions: rash, itching, or anaphylaxis. - Thromboembolic events: rare clot formation. - Severe hyponatremic encephalopathy: neurological impairment. - Pulmonary edema: fluid accumulation in lungs.

What precautions apply to Desmopressin Acetate?

Before prescribing Desmopressin acetate, clinicians should consider several safety measures. - Assess serum sodium before initiating: check baseline electrolytes. - Monitor fluid intake: avoid excessive water consumption. - Adjust dose in renal impairment: use lower dose or increase monitoring. - Avoid concomitant use with other antidiuretic agents: risk of hyponatremia. - Pregnancy category B: use only if benefit outweighs risk. - Store at below 25°C: keep in the original pack, protect from moisture.

What does Desmopressin Acetate interact with?

Desmopressin acetate can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Thiazide diuretics: may potentiate antidiuretic effect and hyponatremia. - Carbamazepine: increases risk of hyponatremia. - Other vasopressin analogues: additive water‑retention effect.

Moderate Interactions (Monitor Closely): - NSAIDs: may reduce renal clearance, enhancing effect. - SSRIs: increase hyponatremia risk. - Alcohol: may exacerbate hyponatremia.

Frequently asked questions

What conditions is Minirin used to treat?+
Minirin (desmopressin acetate) is prescribed for central diabetes insipidus, nocturnal enuresis, primary nocturnal polyuria, hemophilia A, and von Willebrand disease. In each case the drug helps to either reduce excessive urine production or increase clotting factor levels, addressing the underlying physiological deficit.
How does desmopressin acetate work in the body?+
Desmopressin acetate mimics the natural hormone vasopressin. It binds to V2 receptors in the kidney’s collecting ducts, prompting insertion of water channels that reabsorb water and concentrate urine. It also stimulates V1 receptors on endothelial cells, causing release of von Willebrand factor and factor VIII, which support blood clotting.
What is the usual dose of Minirin?+
The dose of Minirin is individualized by the prescribing clinician based on the specific indication, patient age, weight, renal function, and response to therapy. Dosage adjustments are made during treatment to achieve the desired clinical effect while minimizing the risk of hyponatremia.
Is Minirin safe to use during pregnancy or breastfeeding?+
Minirin is classified as pregnancy category B, indicating that animal studies have not shown risk to the fetus and there are no adequate human studies. It may be used during pregnancy only if the potential benefit justifies the potential risk. Limited data are available for breastfeeding; the decision should be made by the healthcare provider.
How do I order Minirin from GNH USA?+
To order Minirin, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and any required import documentation.
How does Minirin compare with other antidiuretic drugs?+
Minirin (desmopressin) is a selective V2‑receptor agonist, offering a more targeted antidiuretic effect than non‑selective vasopressin analogues. It has a longer half‑life and a lower risk of vasoconstriction, making it preferable for chronic management of diabetes insipidus and for haemostatic use, whereas older agents may cause more cardiovascular side effects.
What are the recommended storage conditions for Minirin?+
Minirin should be stored at temperatures below 25 °C, in its original packaging to protect it from moisture and light. Do not store in a bathroom or near a heat source. Keep the container tightly closed and out of reach of children.
How is Minirin administered to patients?+
Minirin is taken orally, usually as a tablet or melt‑dose formulation, according to the prescriber’s instructions. It is typically taken with a full glass of water, and the timing (e.g., morning or bedtime) depends on the condition being treated and the desired effect on urine output.
What are the most serious risks associated with Minirin?+
The most serious risks include severe hyponatremia leading to cerebral edema, seizures, or water intoxication. Patients should be monitored for signs of low sodium, such as headache, nausea, confusion, or lethargy, and fluid intake should be regulated to avoid excessive water consumption.
Who should not use Minirin?+
Minirin is contraindicated in patients with known hypersensitivity to desmopressin, uncontrolled hyponatremia, or severe renal impairment that precludes safe fluid balance. Caution is also advised in individuals with a history of epilepsy, heart failure, or pulmonary edema, as they may be more susceptible to fluid overload.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Desmopressin Acetate
Route
Oral Use
Manufacturer
Ferring Gmbh
Origin
EU

Related products